Criticare

criticare
GUFIC’s Criticare products are growing at a rapid rate after attaining countrywide acceptance. We supply to most major hospital chains and medical facilities across India. We focus on providing life saving molecules at competitive prices to serve the ailing population.

Highlights

  • GUFIC has been the first and only company to launch Doxycyline I.V in India for tropical fever.
  • Newer life saving molecules like Caspofungin, Tigecycline and Colistimethate have been launched at less than half price of our competitors
  • Our production facility, for lyophilized injections, is a fully automated with an annual capacity of 30 Million vials.